Certara's Engagement in Key Investor Conferences Ahead

Author: Dylan Bailey Updated: 10-31-2025 08:30 AM

Certara's Presence in Investor Conferences

Certara, Inc. (NASDAQ: CERT), a prominent name in the field of drug development, is gearing up for a series of important investor conferences that emphasize its leadership and innovative contributions to model-informed drug development.

Upcoming Conference Schedule

During these conferences, the management of Certara will provide insights into their strategies and advancements in biopharmaceuticals. The schedule is as follows:

UBS Global Healthcare Conference

This event is set for a Tuesday in November at 2:00 PM ET. Attendees can expect a detailed discussion on Certara's innovative approaches to accelerating medicine development.

Jefferies Global Healthcare Conference in London

Later in November, Certara will participate in the Jefferies Global Healthcare Conference. This is another opportunity to highlight how their efforts are transforming the pharmaceutical landscape.

Stephens Annual Investment Conference

On the same day as the Jefferies Conference, Certara will also be attending the Stephens Annual Investment Conference, offering investors a comprehensive insight into their operations.

Accessing the Webcasts

For those interested in staying informed, live webcasts of the conferences will be available on Certara's investor relations website. These sessions will also be accessible for replay for a duration following the events, ensuring everyone gets a chance to capture important insights.

About Certara

Certara accelerates medicines by utilizing advanced biosimulation software, technology, and service frameworks that transform the traditional processes of drug discovery and development. With a clientele that includes over 2,400 biopharmaceutical companies and regulatory agencies across more than 70 countries, Certara solidifies its role as a global leader in the biopharma industry.

Investor Relations and Contact Information

For further inquiries, individuals can reach out to David Deuchler at Gilmartin Group via email. As an established figure in investor relations, he can provide additional details about Certara's initiatives and future developments.

Frequently Asked Questions

What is Certara's main focus in drug development?

Certara primarily focuses on utilizing biosimulation software and technology to enhance drug discovery and development processes.

When will the investor conferences take place?

The UBS Global Healthcare Conference will occur on a Tuesday in November, followed by the Jefferies Global Healthcare Conference on the same day, and the Stephens Annual Investment Conference.

Where can I find the live webcasts for the conferences?

Live webcasts will be available on Certara's investor relations website and can be replayed afterward for those who cannot attend live.

How many countries does Certara operate in?

Certara operates in over 70 countries, providing services to many biopharmaceutical companies and regulatory bodies worldwide.

Who should I contact for more information about Certara?

For additional inquiries, contact David Deuchler at Gilmartin Group. His expertise is invaluable for addressing investor questions.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.